Who owns YYY - EXCHANGE TRADED CONCEPTS TR - YLD SHS HGH INC based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

EXCHANGE TRADED CONCEPTS TR - YLD SHS HGH INC (YYY) Institutional Ownership

Q: What is CUSIP 301505301?

CUSIP 301505301 is the security identifier used in SEC filing datasets for YYY - EXCHANGE TRADED CONCEPTS TR - YLD SHS HGH INC.

CUSIP: 301505301

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2020

Type / Class: Equity / YLD SHS HGH INC
Symbol: YYY

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 301505301?
CUSIP 301505301 identifies YYY - EXCHANGE TRADED CONCEPTS TR - YLD SHS HGH INC in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 301505301:

Q2 2020 (0 holders) Q1 2020 (1 holder) Q4 2019 (0 holders) Q3 2019 (26 holders) Q2 2019 (31 holders) Q1 2019 (28 holders) Q4 2018 (30 holders) Q3 2018 (31 holders) Q2 2018 (29 holders) Q1 2018 (30 holders)

Institutional Holders of EXCHANGE TRADED CONCEPTS TR - YLD SHS HGH INC (YYY) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2020 Q2	0	$0	-$199,000		0
2020 Q1	15,578	$199,000	+$199,000	$12.77	1
2019 Q4	0	$0	-$27,780,212		0
2019 Q3	1,560,731	$27,780,212	-$879,887	$17.80	26
2019 Q2	1,608,563	$28,829,254	+$1,521,438	$17.92	31
2019 Q1	1,429,464	$25,231,160	-$967,164	$17.65	28
2018 Q4	1,492,252	$23,934,010	+$2,403,965	$16.04	30
2018 Q3	1,323,946	$24,280,288	+$3,385,060	$18.34	31
2018 Q2	1,138,617	$20,685,860	+$52,371	$18.16	29
2018 Q1	1,130,491	$20,795,529	+$952,605	$18.40	30
2017 Q4	1,094,763	$21,336,254	-$4,023,846	$19.48	24
2017 Q3	1,265,066	$25,062,454	+$2,769,988	$19.79	22
2017 Q2	1,105,113	$21,618,070	+$6,749,434	$19.56	24
2017 Q1	760,415	$14,473,788	+$4,064,269	$19.03	20
2016 Q4	538,675	$10,002,579	+$196,953	$18.57	20
2016 Q3	525,392	$10,172,594	+$4,532,648	$19.37	23
2016 Q2	291,955	$5,458,000	-$1,911,101	$18.67	19
2016 Q1	299,899	$5,429,059	-$2,162,471	$18.17	17
2015 Q4	421,640	$7,517,437	-$2,515,772	$17.82	22
2015 Q3	551,892	$9,833,861	+$2,786,490	$17.79	20
2015 Q2	395,156	$8,008,212	-$469,184	$20.29	14
2015 Q1	415,145	$8,781,397	+$581,324	$21.15	15
2014 Q4	404,624	$8,365,111	+$1,229,422	$21.60	19
2014 Q3	323,941	$6,986,748	+$2,161,596	$23.00	17
2014 Q2	220,206	$5,066,751	+$1,563,273	$24.48	16
2014 Q1	154,246	$3,337,466	+$916,496	$23.42	14